Finnish pharmaceuticals producer Tamro reported total turnover of 10.74 billion markka ($2.33 billion) for 1995, according to The Baltic Times. Its hospital and laboratory division, dealing with medical equipment, recorded sales of $1 million last year, up 13%.
The company earned 155 million markka from exports to Estonia and Latvia in 1995, compared with 143 million markka in 1994. The Baltic Times also reports that Tamro is predicting good profits for this year from its business in Finland and the Baltic states.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze